Dyck
Pages
-
-
1993 Canadian Journal of Psychiatry Paxil
-
Help your depressd patients find the strength they need when anxiety symptoms intensify the burden. Nine out of ten depressed patients also suffer from symptoms of anxiety. Current evidence shows that over 90% of depressed patients suffer from concurrent anxiety symptoms, including worry and psychic or somatic anxiety. And investigators in a recent study concluded that anxiety symptoms must be relieved in order to treat the underlying depression. Introducing Paxil: as effective as tricyclic antidepressants at lifting depression and associated anxiety symptoms. Clinical studies have found Paxil to be at least as effective as imipramine and amitriptyline at lifting symptoms measured by the Hamilton Rating Scale for Depression, and as effective as imipramine in relieving anxiety symptoms according to both HAM-D and Covi Anxiety Scales. Introducing Paxil: better tolerated than tricyclic antidepressants, to avoid adding to the strain. Paxil is the most selective serotonin reuptake inhibitor available in Canada, so side effects may be less of a concern. Paxil has proven to be better tolerated than imipramine and amitriptyline, with a lower incidence of anticholinergic effects. Once a day Paxil ending the dark night of depression and its anxiety., Paroxetine HCI, SmithKline Beecham, An image of the Greek God Atlas, holding the weight of the world upon his shoulders. Also an image of a sun is pictured.
-
-
1993 Canadian Journal of Psychiatry Prozac
-
First line therapy for depression, Prozac helps provide…effective relief from depression and from the symptoms of anxiety and insomnia associated with depression, improved compliance with 20 mg capsule, once a day, from start to finish of treatment for many patients. If you would like to receive more drug information or information on available patient education please call 1-800-663-3363 Ext. 12. Prozac as your first line of action., Fluoxetine Hydrochloride, Eli Lilly and Company, A black-and-white photo of a women's face; she has a neutral expression on her face. There are blue lines that are seen across the ad. Also, the "O'" in "Prozac" looks like a sunset.
-
-
1993 Canadian Journal of Psychiatry Prozac
-
For patients suffering from depression. Prozac as your first line of action. Helps provide your patients with…effective relief from depression. Fewer therapy limiting side effects when compared to TCAs. Compliance through convenient once a day dosing. A wider margin of safety in overdose than TCAs. Effective relief from the symptoms of anxiety and insomnia associated with depression., Fluoxetine Hydrochloride, Eli Lilly and Company, An image of 3 people, 1 male and 2 female; they all have a blank expression on their face. Also an image of a drug bottle which is sitting on a life saver floatation device labeled "Prozac."
-
-
1993 Canadian Journal of Psychiatry Restoril
-
All hypnotics are effective. So why choose Restoril? Concerned about hypnotic use? Prescribe Restoril for what it doesn't do: low potential for rebound insomnia upon withdrawal, low potential for memory disturbances, helps avoid next-day impairment, no interference with REM sleep shown in studies. Need hypnotic efficacy? Prescribe Restoril for what it does. Intermediate half-life (8 to 10 hours), to help provide a full night's sleep. Gradual onset of action, to help your patients avoid the "knock-out" habit. For short term use Restoril an answer to the growing concern about hypnotics., Temazepam, Sandoz, 5 standard pins are pictured; in between them, there is a larger safety pin that is pictured; the safety pin is meant to stand out with respect to the standard pins.
-
-
1993 Canadian Journal of Psychiatry Risperdal
-
New. Introducing an important advance in the first-line treatment of schizophrenia. Introducing Risperdal. First-line therapy that brings together the control of both positive and negative symptoms with significantly less EPS. The elusive goal of antipsychotic therapy has always been to curb the symptoms of schizophrenia without encumbering the patient. Too often, subduing the disease has meant subjecting the patient to a disturbed array of side effects. And the ability to control negative symptoms has lagged far behind the control of positive symptoms. Now there is Risperdal. Bringing the proven efficacy and safety profile of a uniquely-balanced serotonin/dopamine antagonist (SDA) to the first-line treatment of schizophrenia. In clinical trials, Risperdal has consistently performed better than haloperidol in controlled positive symptoms and has been dramatically more effective on negative symptoms. Risperdal has demonstrated an excellent tolerability profile, with the most common side effects being insomnia, agitation, anxiety, headahce, and extrapyramidal side effects. However, at optimal dosing, these side effects, including EPS, are virtually the same as placebo. Risperdal. A new class of antipsychotic (SDA) that provides both positive and negative symptoms control with significantly less EPS. Uniquely-balanced serotonin/dopamine antagonism. New Risperdal Positive and negative symptoms control with significantly less EPS. Risperdal first-line therapy that can be the first step in helping to reconstruct the life shattered by schizophrenia. Advantages for patients with schizophrenia, in comparison to haloperidol: greater success in treating positive symptoms, proven success in treating negative symptoms, significantly fewer extrapyramidal side effects (EPS), improved tolerability helps promote compliance. Risperdal is a novel, uniquely-balanced serotonin/dopamine anatgonist. Which may well explain its greater efficacy and safety over a conventional neuroleptic like haloperidol. With its proven symptoms control, low EPS profile and faster onset of action, Risperdal should be of benefit to a wide range of patients with schizophrenia. As well, its low incidence of EPS can be expected to help promote compliance. And at therapeutic doses, Risperdal has demonstrated a marked reduction in total dyskinesia scores, particularly in patients suffering from pre-existing tardive dyskinesia. Risperdal. First-line therapy that can be the first step in helping to reconstruct the life shattered by schizophrenia. Greater success in treating positive symptoms. Proven success in treating negative symptoms. Extrapyramidal side effects at optimal dosing similar to placebo., Risperidone, Janssen, A women's face is pictured multiple times. First, she is black and white, negative expression, face broken in half. Then she is pictured in colour, face back together, neutral expression, surrounded by green and yellow thick lines (drug logo).
-
-
1993 Canadian Journal of Psychiatry Rivotril
-
Rivotril. To help weather the storm., Clonazepam, Roche, A drawing of a tornado, with the top (head) of the tornado being a large brain. There is bright light seen in the clouds behind the brain tornado.
-
-
1993 Canadian Journal of Psychiatry Roxiam
-
For years they've been called 'acceptable' side effects. Now a new drug can change all that. Introducing Roxiam. An advance in the treatment of schizophrenia. For years effective management of schizophrenia has often come at a terrible price. Extrapyramidal symptoms, especially severe tremors, akathisia and rigidity remain troubling roadblocks. But now a new atypical neuroleptic with efficacy equal to haloperidol means there can be a clearer path to recovery. New Roxiam (remoxipride), with its highly selective pharmacological action of bloking D2 receptors, has consistently shown to be effective in controlling both the positive and negative symptoms in schizophrenia, with reduced adverse effects compared to haloperidol. Clinical trials have shown that adverse reactions are less frequent and often less severe with Roxiam treated patients than those treated with haloperidol. Studies have further shown that anticholinergic medications were less frequently prescribed as concomitant medication in order to counteract adverse extrapyramidal reactions in the Roxiam groups than among haloperidol recipients. With Roxiam, the management of schizophrenia takes and important stride forward. And the ground gained was worth the wait. Roxiam helps separate the benefits of control from the burden of side effects., Remoxipride, Astra, A blurry image of a man dressed in black, looking toward the ground, with his hands together as they appear to be shaking. Also pictured is a graph comparing side effects. The Roxiam logo is a pink and blue object put together to make a cube.
-
-
1993 Canadian Journal of Psychiatry Tegretol CR
-
Drugs that treat manic-depression shouldn’t be manic. Tegretol CR is specifically designed to reduce peak-related CNS side effects, such as dizziness and drowsiness that may be associated with conventional carbamaepine. And this long-term anti-manic treatment is available in easy to break 200mg and 400mg tablets for convenient BID dosage. So when prescribing treatment for bipolar disorders, be specific, Tegretol CR. An improved carbamazepine., Carbamazepine, Geigy, The background of the ad has small doodles and markings on it, like fingerprints. Part of the ad is written as if it is painted. Also, a graph of plasma carbamazepine concentrations. Also pictured is 2 tablets.
-
-
1993 Canadian Journal of Psychiatry Zoloft
-
Antidepressant therapy that causes insomnia can prevent a patient from flourishing during the day. Zoloft delivers first-line SSRI antidepressant efficacy with little potential for agitation or sedation. Zoloft (sertraline HCl/Pfizer) offers patients an escape from the confines of depression, with little risk of agitation, insomnia or sedation to hinder their return to a fulfilling life. While relieving the symptoms of depression with efficacy comparable to imipramine and amitriptyline, Zoloft has virtually no detrimental effect on psychomotor and cognitive performance that can interfere with daytime functioning - and may result in non-compliance to therapy. Favourable safety profile. Tricyclics have a narrower therapeutic margin, particularly in the elderly, and may cause serious drug intoxication. In cases of overdose at up to 10 times the maximum recommended dose of Zoloft, all patients have made a complete recovery. Zoloft has few cardiac effects and is not associated with significant ECG abnormalities. Favourable pharmacokinetic profile. Zoloft has no intrinsic anticholinergic activity to cause the troubling side effects traditionally associated with antidepressant therapy. And Zoloft produces no clinically active metabolites, has a significantly shorter half-life than fluoxetine and a low risk of drug interaction. In fact, Zoloft can usually be prescribed for the elderly with no dosage adjustment. Zoloft. Effective liberation from depression with few side effects to compromise your patient's recovery. Zoloft once a day. Day or night., Sertraline HCI, Pfizer, A women in a yellow dress sitting inside a clear/glass flower; she appears to be trapped. That same women is then pictured holding that flower in her hand, and performing some sort of arts and crafts with it.
-
-
1993 Canadian Journal of Psychiatry Zoloft
-
Now on the Ontario Drug Benefit Formulary. Zoloft delivers first-line SSRI antidepressant efficacy with virtually no agitation or sedation. Zoloft (sertraline HCl/Pfizer) allows your patients to enjoy the benefits of antidepressant therapy with little risk of agitation, insomnia, or sedation. While relieving the symptoms of depression with efficacy comparable to imipramine and amitriptyline, Zoloft has virtually no detrimental effect on psychomotor and cognitive performance that can interfere with daytime functioning - and may results in non-compliance to therapy. Favourable safety profile. While tricyclics have significant cardiovascular effects at therapeutic doses, Zoloft has few cardiac effects and is not associated with significant ECG abnormalities. Favourable pharmacokinetic profile. Zoloft has no intrinsic anti-cholinergic activity to cause the troubling side effects traditionally associated with antidepressant therapy. And Zoloft produces no clinically active metabolites, has a significantly shorter half-life then fluoxetine, and a low risk of drug interaction. In fact, Zoloft can usually be prescribed for the elderly with no dosage adjustment. Zolost antidepressant efficacy with few side effects to compromise your patient's recovery., Sertraline HCI, Pfizer, A woman, with a neutral expression, working on some sort of art project. She is holding a clear flower in her hand with a flame pointed toward the object, as she is holding a glass rod to the flame.
-
-
1993 Der Nervenarzt Akatinol Memantine
-
The therapuetic perspective in demential syndrome. Modulation of disturbed glutamatergic neurotransmission. Reactivation of Pyschomotor ability. Akatinol Memantine. Is neuroprotective in excessive glutamate stimulation by NMDA receptor blockade. Activates glutamate release by AMPA receptor stimulation., Memantine, Merz Pharma, Image of a neuron firing with the use of this drug.
-
-
1993 Der Nervenarzt Antares 120
-
Immediately with Tempo 120 in Kava therapies. Antares 120. New. The only Phyto-anxiolytic with 120 mg. Quicker effectiveness. Well tolerated. Divisible natural tablet. Better patient compliance. Quicker Anxiolysis. Without risk of addiction., Kava-Kava Extract, Krewel-Werke GmbH, Image of a Southeast Asian man in cultural garb crouching and holding a bowl. He appears to have a negative expression on his face.
Pages
